Literature DB >> 21835657

Movement disorder emergencies in childhood.

F J Kirkham1, P Haywood, P Kashyape, J Borbone, A Lording, K Pryde, M Cox, J Keslake, M Smith, L Cuthbertson, V Murugan, S Mackie, N H Thomas, A Whitney, K M Forrest, A Parker, R Forsyth, C M Kipps.   

Abstract

The literature on paediatric acute-onset movement disorders is scattered. In a prospective cohort of 52 children (21 male; age range 2mo-15y), the commonest were chorea, dystonia, tremor, myoclonus, and Parkinsonism in descending order of frequency. In this series of mainly previously well children with cryptogenic acute movement disorders, three groups were recognised: (1) Psychogenic disorders (n = 12), typically >10 years of age, more likely to be female and to have tremor and myoclonus (2) Inflammatory or autoimmune disorders (n = 22), including N-methyl-d-aspartate receptor encephalitis, opsoclonus-myoclonus, Sydenham chorea, systemic lupus erythematosus, acute necrotizing encephalopathy (which may be autosomal dominant), and other encephalitides and (3) Non-inflammatory disorders (n = 18), including drug-induced movement disorder, post-pump chorea, metabolic, e.g. glutaric aciduria, and vascular disease, e.g. moyamoya. Other important non-inflammatory movement disorders, typically seen in symptomatic children with underlying aetiologies such as trauma, severe cerebral palsy, epileptic encephalopathy, Down syndrome and Rett syndrome, include dystonic posturing secondary to gastro-oesophageal reflux (Sandifer syndrome) and Paroxysmal Autonomic Instability with Dystonia (PAID) or autonomic 'storming'. Status dystonicus may present in children with known extrapyramidal disorders, such as cerebral palsy or during changes in management e.g. introduction or withdrawal of neuroleptic drugs or failure of intrathecal baclofen infusion; the main risk in terms of mortality is renal failure from rhabdomyolysis. Although the evidence base is weak, as many of the inflammatory/autoimmune conditions are treatable with steroids, immunoglobulin, plasmapheresis, or cyclophosphamide, it is important to make an early diagnosis where possible. Outcome in survivors is variable. Using illustrative case histories, this review draws attention to the practical difficulties in diagnosis and management of this important group of patients.
Copyright © 2011 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21835657     DOI: 10.1016/j.ejpn.2011.04.005

Source DB:  PubMed          Journal:  Eur J Paediatr Neurol        ISSN: 1090-3798            Impact factor:   3.140


  11 in total

Review 1.  Movement Disorders in Metabolic Disorders.

Authors:  José Luiz Pedroso; Orlando G Barsottini; Alberto J Espay
Journal:  Curr Neurol Neurosci Rep       Date:  2019-02-09       Impact factor: 5.081

2.  Movement disorders in emergency settings: a prospective study.

Authors:  Carlo Dallocchio; Angela Matinella; Carla Arbasino; Natale Arno'; Margaret Glorioso; Massimo Sciarretta; Massimiliano Braga; Michele Tinazzi
Journal:  Neurol Sci       Date:  2018-10-15       Impact factor: 3.307

3.  Pediatric Dystonic Storm: A Hospital-Based Study.

Authors:  Jyotindra Narayan Goswami; Shuvendu Roy; Saroj Kumar Patnaik
Journal:  Neurol Clin Pract       Date:  2021-10

4.  Possible Commonalities of Clinical Manifestations Between Dystonia and Catatonia.

Authors:  Kanako Ishizuka; Masako Tachibana; Toshiya Inada
Journal:  Front Psychiatry       Date:  2022-04-29       Impact factor: 4.157

5.  A case of congenital myopathy masquerading as paroxysmal dyskinesia.

Authors:  Harsh Patel; Biswaroop Chakrabarty; Sheffali Gulati; Mehar C Sharma; Lokesh Saini
Journal:  Ann Indian Acad Neurol       Date:  2014-10       Impact factor: 1.383

Review 6.  Utility of Plasmapheresis in Autoimmune-Mediated Encephalopathy in Children: Potentials and Challenges.

Authors:  Abdulhafeez M Khair
Journal:  Neurol Res Int       Date:  2016-04-28

Review 7.  Movement Disorders in Genetic Pediatric Ataxias.

Authors:  Simone Gana; Enza Maria Valente
Journal:  Mov Disord Clin Pract       Date:  2020-04-06

Review 8.  Dystonic opisthotonus: a "red flag" for neurodegeneration with brain iron accumulation syndromes?

Authors:  Maria Stamelou; Scarlett C Lai; Annu Aggarwal; Susanne A Schneider; Henry Houlden; Tu-Hsueh Yeh; Amit Batla; Chin-Song Lu; Mohit Bhatt; Kailash P Bhatia
Journal:  Mov Disord       Date:  2013-06-04       Impact factor: 10.338

9.  Clinical characteristics of acute drug-induced dystonia in pediatric patients.

Authors:  Hyun Woong Park; Jae Ryung Kwak; Ji Sook Lee
Journal:  Clin Exp Emerg Med       Date:  2017-09-30

Review 10.  Review of Hereditary and Acquired Rare Choreas.

Authors:  Daniel Martinez-Ramirez; Ruth H Walker; Mayela Rodríguez-Violante; Emilia M Gatto
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2020-08-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.